APA (7th ed.) Citation

Jennemann, R., Volz, M., Frias-Soler, R. C., Schulze, A., Richter, K., Kaden, S., & Sandhoff, R. (2025). Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin. International Journal of Molecular Sciences, 26(1), 304. https://doi.org/10.3390/ijms26010304

Chicago Style (17th ed.) Citation

Jennemann, Richard, Martina Volz, Roberto Carlos Frias-Soler, Almut Schulze, Karsten Richter, Sylvia Kaden, and Roger Sandhoff. "Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin." International Journal of Molecular Sciences 26, no. 1 (2025): 304. https://doi.org/10.3390/ijms26010304.

MLA (9th ed.) Citation

Jennemann, Richard, et al. "Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin." International Journal of Molecular Sciences, vol. 26, no. 1, 2025, p. 304, https://doi.org/10.3390/ijms26010304.